STAMFORD, Conn., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA), a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of ...
STAMFORD, Conn., Jan. 22, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics (CARA), Inc. today announced it will focus its resources on the oral difelikefalin Phase 2/3 clinical program in notalgia ...
STAMFORD, Conn., Feb. 08, 2023 (GLOBE NEWSWIRE) -- Cara Therapeutics (CARA), Inc. , a commercial-stage biopharmaceutical company leading a new treatment paradigm to improve the lives of patients ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback